Mohit Mohsen, Nejati Mohammadali, Hejazi Najmeh, Modaresi Shayan
Student Research Committee, Department of Clinical Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Internal Medicine, Gastroenterohepatology Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Avicenna J Phytomed. 2024 May-Jun;14(3):338-348. doi: 10.22038/AJP.2024.23927.
This study aimed to assess the effect of sumac supplement in biochemical and anthropometric measurements in overweight or obese patients with non-alcoholic fatty liver disease.
In this double-blind randomized controlled trial, 45 NAFLD patients were randomly divided into two groups. The intervention group received sumac capsules (3 g/day) with a balanced diet for 8 weeks, while the placebo group received placebo with a balanced diet. Anthropometric indices, lipid profile, fasting blood glucose, insulin, Homeostatic Model Assessment for Insulin Resistance, aspartate transaminase, alanine aminotransferase, high sensitivity C-reactive protein and malondialdehyde were measured at baseline and at the end of the study.
The results revealed a significant decrease in anthropometric indices (weight (p=0.001), body mass index (p=0.001), waist circumference (p=0.001), body fat mass (p=0.001), body fat percentage (p=0.001), visceral fat score (p=0.001), biochemical levels of total cholesterol (p=0.007), fasting blood sugar (p=0.006), insulin (p=0.004) and HOMA-IR (p=0.002)) after the intervention compared to the baseline. However, no significant difference was observed between the two groups concerning anthropometric and biochemical indices.
In this study, no significant differences were observed between the two groups regarding anthropometric and biochemical indices. Thus, further studies with larger sample sizes are recommended to be conducted on the issue.
本研究旨在评估漆树补充剂对超重或肥胖非酒精性脂肪性肝病患者生化指标和人体测量指标的影响。
在这项双盲随机对照试验中,45名非酒精性脂肪性肝病患者被随机分为两组。干预组接受漆树胶囊(3克/天)并搭配均衡饮食,持续8周,而安慰剂组接受安慰剂并搭配均衡饮食。在基线和研究结束时测量人体测量指标、血脂谱、空腹血糖、胰岛素、胰岛素抵抗稳态模型评估、天冬氨酸转氨酶、丙氨酸转氨酶、高敏C反应蛋白和丙二醛。
结果显示,与基线相比,干预后人体测量指标(体重(p=0.001)、体重指数(p=0.001)、腰围(p=0.001)、体脂肪量(p=0.001)、体脂肪百分比(p=0.001)、内脏脂肪评分(p=0.001))、总胆固醇生化水平(p=0.007)、空腹血糖(p=0.006)、胰岛素(p=0.004)和HOMA-IR(p=0.002)均显著下降。然而,两组在人体测量和生化指标方面未观察到显著差异。
在本研究中,两组在人体测量和生化指标方面未观察到显著差异。因此,建议针对该问题开展更大样本量的进一步研究。